James C Cunningham MD
EVP/CMO, Cook Children’s Health Care System
Join to View Full Profile
Cook Children's Dodson Specialty Clinics1500 Cooper St 2nd FloorFort Worth, TX 76104
Phone+1 682-885-6299
Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Cunningham is a pediatric pulmonologist based in Fort Worth, TX, who completed his medical education at the University of Texas Medical Branch School of Medicine, followed by a residency in pediatrics at the University of Oklahoma Health Sciences Center and a fellowship in pediatric pulmonology at the University of Arizona College of Medicine-Tucson. He is currently an honorary/emeritus medical staff member at Cook Children's Medical Center and has been a consultant with the Cook Children's Physician Network since 2012. Dr. Cunningham has been recognized as a Super Doctor and Top MD, and he is a Fellow of the American Academy of Pediatrics. His research contributions include a publication on radioimmunotherapy in colorectal cancer and involvement in a clinical trial for early MRSA therapy in cystic fibrosis.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Pediatric Pulmonology, 1984 - 1987
University of Oklahoma Health Sciences CenterResidency, Pediatrics, 1981 - 1984
University of Texas Medical Branch School of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1981 - 2026
AZ State Medical License 1985 - 1988
OK State Medical License 1982 - 1986
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 71 citationsPhase II radioimmunotherapy trial with 131I-CC49 in colorectal cancerJames L. Murray, Daniel J. Macey, L. P. Kasi, Paula Trahan Rieger, Joan E. Cunningham
Cancer. 1994-02-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
